Literature DB >> 34485806

Report of Canonical BCR-ABL1 Fusion in Glioblastoma.

Ying Pang1, Guangyang Yu1, Madison Butler1, Sivasish Sindiri2, Young K Song2, Jun S Wei2, Xinyu Wen2, Hisen-Chao Chou2, Martha Quezado3, Svetlana Pack3, Liqiang Xi3, Zied Abdullaev3, Olga Kim1, Alice Ranjan1, Mythili Merchant1, Ramya Antony1, Lisa Boris1, Orwa Aboud1,4, David Kamson1,4, Rosandra Kaplan5, Megan Mackey6, Kevin Camphausen6, Kareem Zaghloul7, Terri S Armstrong1, Mark R Gilbert1, Kenneth Aldape3, Matthias Holdhoff8, Javed Khan2, Jing Wu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34485806      PMCID： PMC8407655          DOI： 10.1200/PO.20.00519

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  20 in total

Review 1.  Using the molecular classification of glioblastoma to inform personalized treatment.

Authors:  Adriana Olar; Kenneth D Aldape
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

2.  A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia.

Authors:  L C Chan; K K Karhi; S I Rayter; N Heisterkamp; S Eridani; R Powles; S D Lawler; J Groffen; J G Foulkes; M F Greaves; L M Wiedemann
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

Review 3.  Fusion genes: A promising tool combating against cancer.

Authors:  Xiaofeng Dai; Rutaganda Theobard; Hongye Cheng; Mengtao Xing; Jianying Zhang
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 10.680

4.  The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.

Authors:  Te Whiti Rogers; Gurvinder Toor; Katharine Drummond; Craig Love; Kathryn Field; Rebecca Asher; Alpha Tsui; Michael Buckland; Michael Gonzales
Journal:  J Neurooncol       Date:  2017-12-07       Impact factor: 4.130

5.  Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemia.

Authors:  C M Price; F Rassool; M K Shivji; J Gow; C J Tew; C Haworth; J M Goldman; L M Wiedemann
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

Review 6.  Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia.

Authors:  Jane F Apperley
Journal:  Lancet Oncol       Date:  2007-11       Impact factor: 41.316

Review 7.  Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Authors:  Jann N Sarkaria; Leland S Hu; Ian F Parney; Deanna H Pafundi; Debra H Brinkmann; Nadia N Laack; Caterina Giannini; Terence C Burns; Sani H Kizilbash; Janice K Laramy; Kristin R Swanson; Timothy J Kaufmann; Paul D Brown; Nathalie Y R Agar; Evanthia Galanis; Jan C Buckner; William F Elmquist
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

8.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

9.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.

Authors:  B J Druker; S Tamura; E Buchdunger; S Ohno; G M Segal; S Fanning; J Zimmermann; N B Lydon
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

10.  Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.

Authors:  Fernando L Pagan; Michaeline L Hebron; Barbara Wilmarth; Yasar Torres-Yaghi; Abigail Lawler; Elizabeth E Mundel; Nadia Yusuf; Nathan J Starr; Joy Arellano; Helen H Howard; Margo Peyton; Sara Matar; Xiaoguang Liu; Alan J Fowler; Sorell L Schwartz; Jaeil Ahn; Charbel Moussa
Journal:  Pharmacol Res Perspect       Date:  2019-03-12
View more
  1 in total

1.  Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.

Authors:  Guangyang Yu; Ying Pang; Mythili Merchant; Chimene Kesserwan; Vineela Gangalapudi; Abdalla Abdelmaksoud; Alice Ranjan; Olga Kim; Jun S Wei; Hsien-Chao Chou; Xinyu Wen; Sivasish Sindiri; Young K Song; Liqiang Xi; Rosandra N Kaplan; Terri S Armstrong; Mark R Gilbert; Kenneth Aldape; Javed Khan; Jing Wu
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.